Department of Medicine, St. Vincent's Medical Center, Bridgeport, Connecticut; The Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, Connecticut.
Department of Medicine, AdventHealth, Orlando, Florida.
Am J Med Sci. 2019 Nov;358(5):350-356. doi: 10.1016/j.amjms.2019.07.009. Epub 2019 Jul 27.
Diabetic ketoacidosis entails a huge health burden among patients with diabetes. Atrial fibrillation (AF) is the most common type of heart arrhythmia. This study aimed to evaluate the impact of AF on clinical outcomes in patients with diabetic ketoacidosis.
Using the 2012-2014 National Inpatient Sample database, we identified adult patients hospitalized with diabetic ketoacidosis as the principal discharge diagnosis. The identified admissions were stratified into 2 cohorts based on the AF presence. We used multivariable regression models and propensity score matching models to evaluate in-hospital mortality, length of stay, comorbidities, and in-hospital complications.
The study included 478,890 adult patients who were admitted for diabetic ketoacidosis in the year 2012-2014. A total of 467,780 (97.68%) had no AF and 11,125 (2.32%) had AF. In both multivariable regression models and propensity score matching models, compared with nonatrial fibrillation group, the AF group had higher in-hospital mortality rates (2.36 [1.69-3.32], P < 0.001) and longer length of stay (5.5 versus 3.3 days, P < 0.001). AF was also associated with a significantly higher incidence of complications including septic shock, pulmonary failure, mechanical ventilation, neurological failure, cerebral edema, acute kidney injury, acute hematologic failure, and cardiac arrest.
Among patients who were hospitalized for diabetic ketoacidosis, comorbid AF led to increasing in-hospital mortality rates and longer length of stay. A potential explanation was that AF increased the risk of in-hospital complications including respiratory failure with a more frequent requirement for mechanical ventilation, cardiac arrest, and metabolic encephalopathy.
糖尿病酮症酸中毒给糖尿病患者带来了巨大的健康负担。心房颤动(AF)是最常见的心律失常类型。本研究旨在评估 AF 对糖尿病酮症酸中毒患者临床结局的影响。
使用 2012-2014 年全国住院患者样本数据库,我们确定了以糖尿病酮症酸中毒为主要出院诊断的成年住院患者。根据 AF 的存在,将这些入院患者分为 2 个队列。我们使用多变量回归模型和倾向评分匹配模型评估住院死亡率、住院时间、合并症和住院并发症。
本研究纳入了 2012-2014 年因糖尿病酮症酸中毒住院的 478890 名成年患者。共有 467780 名(97.68%)患者无 AF,11125 名(2.32%)患者有 AF。在多变量回归模型和倾向评分匹配模型中,与非心房颤动组相比,心房颤动组的住院死亡率更高(2.36[1.69-3.32],P<0.001),住院时间更长(5.5 天 vs. 3.3 天,P<0.001)。AF 还与并发症的发生率显著增加相关,包括感染性休克、呼吸衰竭、机械通气、神经功能衰竭、脑水肿、急性肾损伤、急性血液学衰竭和心脏骤停。
在因糖尿病酮症酸中毒住院的患者中,合并 AF 导致住院死亡率增加和住院时间延长。一种潜在的解释是,AF 增加了呼吸衰竭的风险,需要更频繁地进行机械通气、心脏骤停和代谢性脑病等并发症的风险。